Participants 0 158 4
N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical tria
Participants 489 689 7
participants were referred outpatients between 4 and 12 years of age with the diagnosis of ADs and a score of more than 12 on Aberrant Behavior Checklist-Community (ABC-C) Irritability subscale score.
Participants 808 833 3
risperidone plus placebo.
Participants 1127 1170 5
Forty patients completed the 10-week trial.
